As of 18 Oct 2026, Nectar Lifescience Ltd share price is ₹10.55. The stock opened at ₹10.55 and had closed at ₹10.05 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹9.20 and a high of ₹22.49. In terms of performance, Nectar Lifescience Ltd share price has decreased by 14.71% over the past six months and has decreased by 22.31% over the last year.
NECLIFE Stock Price Chart
Nectar Lifescience Ltd Overview
About NECLIFE
Nectar Lifescience is engaged in Company undertook significant restructuring and asset monetization initiatives including slump sale/business transfer arrangements relating to certain manufacturing units/ business undertakings, monetization of identified land parcels and other non-core assets.
Nectar Lifescience Ltd Historical Performance
Nectar Lifescience Ltd Fundamentals
Nectar Lifescience Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 9.29 | 1.88 | 1,698.66 | 1,566.85 | 1,679.55 |
| EBITDA | -51.40 | 3.16 | 166.14 | 97.91 | 170.13 |
| Net Profit | -292.88 | -113.68 | 5.00 | -22.46 | 25.32 |
| EPS | -13.40 | -5.07 | 0.22 | -1.00 | 1.17 |
Nectar Lifescience Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 9.94 |
| Resistance 1 (R1) | 10.24 |
| Pivot Point | 10.12 |
NECLIFE Key Leadership Details
Last Updated: Mar 2026
| Name | Position |
|---|---|
| Sanjiv Goyal | Chairman |
| Rupinder Tewari | Non Executive Independent Director |
| Kuldip Kumar Bhasin | Non Executive Independent Director |
Nectar Lifescience Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,758.80-0.29% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,144.50+1.27% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,558.90-0.55% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Nectar Lifescience Ltd today is ₹10.55 on NSE and ₹10.55 on BSE.
- The 52-week high of Nectar Lifescience Ltd is ₹22.49, while the 52-week low is ₹9.20.
- The current market capitalisation of Nectar Lifescience Ltd is approximately ₹205 crore.
- The P/E (Price-to-Earnings) ratio of Nectar Lifescience Ltd is -0.66. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Nectar Lifescience Ltd is 0.33. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Nectar Lifescience Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for NECLIFE on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Nectar Lifescience Ltd has delivered a return of approximately -56.87%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Nectar Lifescience Ltd comprises different categories of shareholders. As of Sept 2026, the shareholding is approximately 51.84% promoters, 0.50% FIIs, 3.90% DIIs, and 37.62% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
